Atlas Trials

Invivyd, Inc.

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Invivyd, Inc.

RecordFirmDate
Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine (NCT07655180)Invivyd, Inc.2026-06-08
Study of VYD2311 for the Prevention of COVID-19 (NCT07298434)Invivyd, Inc.2026-01-08
A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants (NCT06523153)Invivyd, Inc.2024-08-28
A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2 (NCT06039449)Invivyd, Inc.2023-09-08
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of the Monoclonal Antibody VYD222 in Healthy Adult Participants (NCT05791318)Invivyd, Inc.2023-03-28
Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19 (NCT04805671)Invivyd, Inc.2021-07-26
Evaluation of ADG20 for the Prevention of COVID-19 (NCT04859517)Invivyd, Inc.2021-04-27
Provide Pre-approval Single-patient Expanded Access (Compassionate Use) of VYD222 for Patients With Symptomatic COVID-19 Refractory to Other Treatments (NCT06004128)Invivyd, Inc.

Track Invivyd, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.